A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Cardiovascular disorder

Not recruiting

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pelacarsen
Sponsor:Novartis Pharma AG

Contact Research Centre

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Evolocumab
Sponsor:Amgen Inc.

Contact Research Centre

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Atorvastatin
Sponsor:Novartis Pharma AG

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Gouda

What the registry says about research in the country

01 Cardiovascular Research

Comprehensive studies focusing on atherosclerotic cardiovascular disease and innovative treatments for reducing major adverse cardiovascular events. Research includes evaluation of new therapies like pelacarsen and inclisiran.

Heart Disease Prevention
Vascular Health
Lipid Management

Multiple trials investigating treatments for peripheral arterial disease and heart failure conditions.

02 Oncology Studies

Advanced research in cancer treatment, particularly focusing on breast cancer, colorectal cancer, and innovative approaches to chemotherapy administration.

Breast Cancer Therapies
Colorectal Cancer Management
Personalized Treatment Approaches

Studies exploring dose optimization and novel drug combinations for better patient outcomes.

03 Hematological Research

Cutting-edge investigations into chronic lymphocytic leukemia treatments, evaluating combinations of targeted therapies including ibrutinib and venetoclax.

Leukemia Treatment
Blood Cancer Therapies
Immunotherapy Approaches

Focus on developing more effective treatment strategies for blood cancers.

Back to the Netherlands All countries